Back to Evidence
Primary experimental recordPositive observation

PMC12891685::ACT035929

MAGE

Evidence text

Paper-level observation

In the GrB ELISPOT we saw an increase in immune responses for ... MAGE/anti-PD-1 for the R of ... 4.7-fold (Fig. 3C).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Antibacterial
Measure
fold_change
Comparator
=
Raw observation
4.7-fold
Normalized measurement
=4.7
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
SLLMWITQC
Standardization
ready simple

Source publication

Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer

Scientific Reports · 2026

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.